Real World Experience of Standard of Care Talquetamab in Patients with Relapsed and Refractory Multiple Myeloma

被引：0
|
作者：
Grajales-cruz, Ariel [1 ]
Graeter, Allison [2 ]
Hansen, Doris [1 ]
Puglianini, Omar Castaneda [1 ]
Vazquez-Martinez, Mariola [1 ]
Blue, Brandon [1 ]
Liu, Hien [1 ]
Ochoa-Bayona, Jose [1 ]
Freeman, Ciara [1 ]
Locke, Frederick [1 ]
Nishihori, Taiga [1 ]
Shain, Kenneth [1 ]
Baz, Rachid [1 ]
Alsina, Melissa [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Tampa, FL 33620 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-027
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [31] A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Dileo, Rachel
    Mewawalla, Prerna
    Babu, Kalaivani
    Yin, Yue
    Strouse, Christopher
    Chen, Ethan
    Shaikh, Hira
    Davis, James A.
    Green, Kimberly M.
    Alkharabsheh, Omar
    Rashid, Aliya
    Pokhrel, Bidushi
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [32] Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
    Razzo, Beatrice
    Grajales-Cruz, Ariel
    Atrash, Shebli
    Ferreri, Christopher
    Goyal, Anmol
    Pasvolsky, Oren
    Banerjee, Rahul
    Julian, Kelley
    Forsberg, Peter
    Herr, Megan
    Lin, Yi
    Susanibar-Adaniya, Sandra
    Khouri, Jack
    Vazquez-Martinez, Mariola
    Lee, Hans
    Portuguese, Andrew
    Sborov, Douglas W.
    Dima, Danai
    Davis, James
    Kaur, Gurbakhash
    Shune, Leyla
    Hansen, Doris
    Sidana, Surbhi
    Garfall, Alfred
    Richard, Shambavi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S82 - S83
  • [33] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
    Huang, Shang-Yi
    Chen, Tsai-Yun
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Lin, Sheng-Fung
    Chang, Ming-Chih
    Lv, Xinzhu
    Yang, Betty
    Chang, Cheng-Shyong
    ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
  • [34] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    BLOOD, 2014, 124 (21)
  • [35] Real-world experience of KPD use in relapsed or refractory myeloma
    Barrett, A.
    Gul, F.
    Nee, A.
    O'Leary, H.
    O'Keefe, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 238 - 238
  • [36] Safety and Efficacy of Standard of Care (SOC) Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM), a Single Center Experience
    Grajales-Cruz, Ariel F.
    Hansen, Doris K.
    Castaneda, Omar
    Graeter, Allison
    Vazquez-Martinez, Mariola A.
    Modukuri, Shrikar
    De Avila, Gabriel
    Denson, Ariel
    Fadul, Julia
    Blue, Brandon
    Lopez, Blanca
    Harvey, Kristy
    Thapa, Shrinjaya B.
    Tobon, Katherine
    Melnick, Parker
    Ionescu, Filip
    Liu, Hien
    Ochoa-Bayona, Jose L.
    Freeman, Ciara Louise
    Locke, Frederick
    Nishihori, Taiga
    Shain, Kenneth H.
    Alsina, Melissa
    Baz, Rachid
    BLOOD, 2024, 144 : 7832 - 7833
  • [37] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [38] Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
    Ye, Jing Christine
    Biran, Noa
    Nair, Sandhya
    Lin, Xiwu
    Qi, Keqin
    Londhe, Anil
    Ammann, Eric
    Renaud, Thomas
    Kane, Colleen
    Parekh, Trilok
    Gray, Kathleen
    Peterson, Steve
    Costa, Luciano J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (02):
  • [39] Talquetamab Versus Belgian Real-World Clinical Practice in Triple- Class Exposed Relapsed and Refractory Multiple Myeloma Patients Using Adjusted Comparison
    Vekemans, Marie-Christiane
    Anguille, Sebastien
    Depaus, Julien
    Meuleman, Nathalie
    Van de Velde, Ann
    Vande Broek, Isabelle
    Ghilotti, Francesca
    Trevisan, Marco
    Cabrieto, Jedelyn
    Ghilotti, Francesca
    Trevisan, Marco
    Cabrieto, Jedelyn
    Diels, Joris
    Orel, Oleksiy
    Brok, Ronald
    Vandervennet, Sophie
    Smet, Ann
    Lub, Susanne
    Delforge, Michel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S94 - S95
  • [40] Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
    Catamero, Donna
    Ray, Chloe
    Purcell, Kiah
    Leahey, Sheryl
    Esler, Elaine
    Rogers, Stephanie
    Hefner, Kayla
    O'Rourke, Lisa
    Gray, Kathleen
    Tolbert, Jaszianne
    Renaud, Thomas
    Patel, Saurabh
    Hannemann, Linda
    Shenoy, Samantha
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (05)
12345